[1] MONT MA, PIVEC R, BANERJEE S, et al. High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review. J Arthroplasty. 2015;30(9):1506-1512.
[2] WANG XS, ZHUANG QY, WENG XS, et al. Etiological and clinical analysis of osteonecrosis of the femoral head in Chinese patients. Chin Med J (Engl). 2013;126(2):290-295.
[3] KAMEDA H, AMANO K, NAGASAWA H, et al. Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases. Intern Med. 2009;48(22):1931-1938.
[4] CE P, GEDIZLIOGLU M, GELAL F, et al. Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosis. Eur J Neurol. 2006;13(8):857-861.
[5] SAITO M, UESHIMA K, FUJIOKA M, et al. Corticosteroid administration within 2 weeks after renal transplantation affects the incidence of femoral head osteonecrosis. Acta Orthop. 2014;85(3):266-270.
[6] EKINCI R, BALCI S, CELIK G, et al. Symptomatic multifocal avascular necrosis in an adolescent with neuropsychiatric systemic lupus erythematosus. Reumatologia. 2019;57(3):182-187.
[7] HUSSEIN S, SUITNER M, BELAND-BONENFANT S, et al. Monitoring of Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review and Metaanalysis. J Rheumatol. 2018;45(10):1462-1476.
[8] FUKUSHIMA W, FUJIOKA M, KUBO T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468(10):2715-2724.
[9] NAKAMURA J, OHTORI S, SAKAMOTO M, et al. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence. Clin Exp Rheumatol. 2010;28(1):13-18.
[10] MATTANO LJ, DEVIDAS M, NACHMAN JB, et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012;13(9):906-915.
[11] MCAVOY S, BAKER KS, MULROONEY D, et al. Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010;16(9):1231-1236.
[12] LIM CY, ONG KO. Various musculoskeletal manifestations of chronic renal insufficiency. Clin Radiol. 2013;68(7):e397-e411.
[13] SUN W, LI ZR, SHI ZC, et al. Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population. Int Orthop. 2006; 30(3):143-146.
[14] MEIER R, KRAUS TM, SCHAEFFELER C, et al. Bone marrow oedema on MR imaging indicates ARCO stage 3 disease in patients with AVN of the femoral head. Eur Radiol. 2014;24(9):2271-2278.
[15] CARDENIERS JW. ARCO international stage of osteonecrosis. ARCO Newsletter. 1993;5:79-82.
[16] MAUS U, ROTH A, TINGART M, et al. S3 Guideline. Part 3: non-traumatic avascular necrosis in adults-surgical treatment of atraumatic avascular femoral head necrosis in adults. Z Orthop Unfall. 2015;153(5):498-507.
[17] 李子荣, 刘朝晖, 孙伟, 等. 基于三柱结构的股骨头坏死分型——中日友好医院分型[J]. 中华骨科杂志,2012,32(6):515-520.
[18] 孙伟, 李子荣, 高福强, 等. 磷酸三钙多孔生物陶瓷修复股骨头坏死[J]. 中国组织工程研究,2014,18(16):2474-2479.
[19] SUN W, LI ZR, WANG BL, et al. Relationship between preservation of the lateral pillar and collapse of the femoral head in patients with osteonecrosis. Orthopedics. 2014;37(1): e24-e28.
[20] ROSENWASSER MP, GARINO JP, KIERNAN HA, et al. Long term followup of thorough debridement and cancellous bone grafting of the femoral head for avascular necrosis. Clin Orthop Relat Res. 1994;(306):17-27.
[21] MONT MA, ETIENNE G, RAGLAND PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;(417):84-92.
[22] 李子荣. 股骨头坏死临床诊疗规范[J]. 中华骨与关节外科杂志, 2015,8(1):1-6.
[23] ERIVAN R, CAPUTO T, RIOUACH H, et al. Primary total hip replacement in Ficat-Arlet stage 3 and 4 osteonecrosis: a retrospective study at a minimum 12-year follow-up. Eur J Orthop Surg Traumatol. 2020;30(5): 845-850.
[24] PARK CW, LIM SJ, KIM JH, et al. Hip resurfacing arthroplasty for osteonecrosis of the femoral head: Implant-specific outcomes and risk factors for failure. J Orthop Translat. 2020;21:41-48.
[25] KOBAYASHI S, KUBO T, IWAMOTO Y, et al. Nationwide multicenter follow-up cohort study of hip arthroplasties performed for osteonecrosis of the femoral head. Int Orthop. 2018;42(7):1661-1668.
[26] PIERCE TP, ELMALLAH RK, JAUREGUI JJ, et al. Outcomes of total hip arthroplasty in patients with osteonecrosis of the femoral head-a current review. Curr Rev Musculoskelet Med. 2015;8(3):246-251.
[27] 李子荣. 股骨头坏死:早期诊断与个体化治疗[J]. 中国矫形外科杂志, 2013,21(19):1909-1911.
[28] ANIS HK, SODHI N, EHIOROBO JO, et al. Joint preservation procedures for osteonecrosis. Instr Course Lect. 2020,69:129-138.
[29] 左伟,孙伟,高福强,等. 经头颈部开窗打压植骨治疗股骨头已部分塌陷股骨头坏死疗效分析[J]. 中国修复重建外科杂志, 2016, 30(4):397-401.
[30] SEYLER TM, MARKER DR, ULRICH SD, et al. Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis. Clin Orthop Relat Res. 2008;466(5):1125-1132.
[31] SUN W, LI Z, GAO F, et al. Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis. PLoS One. 2014;9(6):e100424.
[32] EWARD WC, RINEER CA, URBANIAK JR, et al. The vascularized fibular graft in precollapse osteonecrosis: is long-term hip preservation possible? Clin Orthop Relat Res. 2012;470(10):2819-2826.
[33] PHEMISTER DB. Treatment of the necrotic head of the femur in adults. J Bone Joint Surg Am. 1949;31A(1):55-66.
[34] 陈雷雷, 洪志楠, 洪郭驹, 等. 打压支撑植骨术治疗股骨头坏死的中长期疗效与影响因素分析[J]. 中华骨科杂志, 2018,38(7):403-410.
[35] MEYERS MH, JONES RE, BUCHOLZ RW, et al. Fresh autogenous grafts and osteochondral allografts for the treatment of segmental collapse in osteonecrosis of the hip. Clin Orthop Relat Res. 1983;(174):107-112.
[36] SULTAN AA, KHLOPAS A, SURACE P, et al. The use of non-vascularized bone grafts to treat osteonecrosis of the femoral head: indications, techniques, and outcomes. Int Orthop. 2019;43(6):1315-1320.
[37] PIERCE TP, ELMALLAH RK, JAUREGUI JJ, et al. A current review of non-vascularized bone grafting in osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8(3):240-245.
[38] MONT MA, ZYWIEL MG, MARKER DR, et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010;92(12): 2165-2170.
[39] SHIGEMURA T, NAKAMURA J, KISHIDA S, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology(Oxford). 2011;50(11):2023-2028.
[40] SEKIYA F, YAMAJI K, YANG K, et al. Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus. Rheumatol Int. 2010;30(12):1587-1593.
[41] MELONI MC, HOEDEMAEKER WR, FORNASIER V. Failed vascularized fibular graft in treatment of osteonecrosis of the femoral head. A histopathological analysis. Joints. 2016;4(1):24-30.
[42] HAUZEUR JP, MALAISE M, DE MAERTELAER V. A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis. Int Orthop. 2016;40(7):1347-1351.
[43] MONT MA, CARBONE JJ, FAIRBANK AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res. 1996;(324):169-178.
|